The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
2.760
+0.030 (1.10%)
Mar 10, 2026, 2:35 PM EDT - Market open

The Oncology Institute Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
461.04393.41324.24252.48203187.52
Revenue Growth (YoY)
21.67%21.33%28.42%24.37%8.26%-
Cost of Revenue
393.06339.42264.67200.39162.16150.64
Gross Profit
67.985459.5752.0940.8536.88
Selling, General & Admin
102.87107.83113.85119.6983.3741.9
Depreciation & Amortization Expenses
7.026.295.874.413.343.18
Other Operating Expenses
--16.879.94--
Total Operating Expenses
109.88114.12136.59134.0486.7145.08
Operating Income
-41.11-60.12-77.02-81.95-45.86-8.2
Interest Expense
-10.53-7.5-6.78-4.08-0.32-0.35
Other Non-Operating Income (Expense)
-14.782.950.6985.9434.58-6.27
Total Non-Operating Income (Expense)
-25.31-4.55-6.0981.8634.26-6.62
Pretax Income
-66.41-64.66-83.1-0.09-11.6-14.82
Provision for Income Taxes
-0.13-0.04-0.240.670.49
Net Income
-58.17-53.01-67.880.07-10.63-14.32
Net Income to Common
-58.17-53.01-67.880.07-10.63-14.32
Shares Outstanding (Basic)
867574736659
Shares Outstanding (Diluted)
867574816659
Shares Change (YoY)
15.25%1.76%-8.51%21.70%12.03%-
EPS (Basic)
-0.64-0.71-0.92--0.16-0.24
EPS (Diluted)
-0.64-0.71-0.92-0.21-0.16-0.24
Free Cash Flow
--30.33-40.88-67.29-35.53-0.69
Free Cash Flow Per Share
--0.40-0.55-0.83-0.54-0.01
Gross Margin
14.74%13.73%18.37%20.63%20.12%19.67%
Operating Margin
-8.92%-15.28%-23.75%-32.46%-22.59%-4.37%
Profit Margin
-14.38%-16.44%-25.62%0.06%-5.38%-7.64%
FCF Margin
--7.71%-12.61%-26.65%-17.50%-0.37%
EBITDA
-41.11-53.83-71.15-77.54-42.52-5.02
EBITDA Margin
-8.92%-13.68%-21.94%-30.71%-20.94%-2.68%
EBIT
-41.11-60.12-77.02-81.95-45.86-8.2
EBIT Margin
-8.92%-15.28%-23.75%-32.46%-22.59%-4.37%
Effective Tax Rate
0.20%0.00%-0.04%267.03%-5.79%-3.33%
Updated Nov 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q